Log In
BCIQ
Print this Print this
 

CUV9900

  Manage Alerts
Collapse Summary General Information
Company Clinuvel Pharmaceuticals Ltd.
DescriptionAlpha melanocyte stimulating hormone (alpha-MSH) analogue
Molecular Target Alpha melanocyte stimulating hormone (alpha-MSH)
Mechanism of Action 
Therapeutic Modality 
Latest Stage of DevelopmentDiscovery
Standard Indication Dermatology (unspecified)
Indication DetailsSkin protectant
Regulatory Designation
PartnerBiotech Lab Singapore Ltd.

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
Total Number of DealsTotal Deal ValueTotal Upfront CashTotal Milestone Payments

1

0

0

0


 Deals Details
DateCompanies InvolvedDeal HeadlineTotal Deal ValueTotal Upfront CashTotal Milestone

09/19/2014

Undisclosed

Undisclosed

Undisclosed

Get a free BioCentury trial today